PHAXIAM Therapeutics SA (PHXM)
US29604W2070 - ADR
ChartMill assigns a Buy % Consensus number of 85% to PHXM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.17. This target is 228.04% above the current price.
PHXM was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PHXM.
In the previous month the buy percentage consensus was at a similar level.
PHXM was analyzed by 8 analysts. More opinions would make the average more meaningful.